JP2002501377A5 - - Google Patents

Download PDF

Info

Publication number
JP2002501377A5
JP2002501377A5 JP1998544147A JP54414798A JP2002501377A5 JP 2002501377 A5 JP2002501377 A5 JP 2002501377A5 JP 1998544147 A JP1998544147 A JP 1998544147A JP 54414798 A JP54414798 A JP 54414798A JP 2002501377 A5 JP2002501377 A5 JP 2002501377A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998544147A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002501377A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/007353 external-priority patent/WO1998046785A1/en
Publication of JP2002501377A publication Critical patent/JP2002501377A/ja
Publication of JP2002501377A5 publication Critical patent/JP2002501377A5/ja
Withdrawn legal-status Critical Current

Links

JP54414798A 1997-04-15 1998-04-15 樹状細胞ハイブリッド Withdrawn JP2002501377A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4360997P 1997-04-15 1997-04-15
US60/043,609 1997-04-15
PCT/US1998/007353 WO1998046785A1 (en) 1997-04-15 1998-04-15 Dendritic cell hybrids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008147567A Division JP2008263997A (ja) 1997-04-15 2008-06-05 樹状細胞ハイブリッド

Publications (2)

Publication Number Publication Date
JP2002501377A JP2002501377A (ja) 2002-01-15
JP2002501377A5 true JP2002501377A5 (https=) 2005-12-02

Family

ID=21928022

Family Applications (2)

Application Number Title Priority Date Filing Date
JP54414798A Withdrawn JP2002501377A (ja) 1997-04-15 1998-04-15 樹状細胞ハイブリッド
JP2008147567A Pending JP2008263997A (ja) 1997-04-15 2008-06-05 樹状細胞ハイブリッド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008147567A Pending JP2008263997A (ja) 1997-04-15 2008-06-05 樹状細胞ハイブリッド

Country Status (8)

Country Link
US (1) US6652848B1 (https=)
EP (1) EP1007720B1 (https=)
JP (2) JP2002501377A (https=)
AT (1) ATE388237T1 (https=)
AU (1) AU744042B2 (https=)
CA (1) CA2286873C (https=)
DE (1) DE69839215T2 (https=)
WO (1) WO1998046785A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273753B2 (en) * 1996-08-02 2007-09-25 Center Of Blood Research Purification and uses of dendritic cells and monocytes
US20050169898A1 (en) 1997-04-15 2005-08-04 Jianlin Gong Cell fusions and methods of making and using the same
WO1999037313A1 (en) * 1998-01-26 1999-07-29 Genzyme Corporation Immune effector cell hybrids
AU2001238236B2 (en) * 1997-04-15 2007-02-15 Dana-Farber Cancer Institute, Inc. Cytotoxic t lymphocytes activated by dendritic cell hybrids
US6389455B1 (en) * 1998-09-22 2002-05-14 Richard C. Fuisz Method and apparatus for bouncing electronic messages
WO2000057705A1 (en) * 1999-03-31 2000-10-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
EP1226235A2 (de) * 1999-10-22 2002-07-31 LESKOVAR, Peter Zellkonstrukte, die für die immuntherapie geeignet sind, deren herstellung und verwendung
KR100363587B1 (ko) * 1999-11-12 2002-12-06 이시우 대식세포와 종양세포의 융합에 의한 항종양 세포성 치료제
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
US20070212338A1 (en) * 2000-01-11 2007-09-13 Greenville Hospital System Hybrid cells
EP1541675A3 (en) * 2000-01-11 2007-08-08 Greenville Hospital System Hybrid cells obtainable from antigen presenting cells
US20090087450A1 (en) 2000-01-11 2009-04-02 Greenville Hospital System Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
CN1427889B (zh) 2000-01-11 2011-06-29 格林维尔医院系统公司 由抗原提呈细胞可获得的杂交细胞
JP5054875B2 (ja) * 2000-02-11 2012-10-24 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド 樹状細胞ハイブリッドによって活性化される細胞傷害性tリンパ球
CA2400636A1 (en) * 2000-02-27 2001-08-30 Eberhard-Karls-Universitat Tubingen Universitatsklinikum Hybrid cell vaccines
DE10009030A1 (de) * 2000-02-27 2001-09-20 Univ Eberhard Karls Impfstoff
DE10024384A1 (de) * 2000-05-17 2001-11-29 Mack Gerd R Herstellung von dendritischen Zellen aus Rückenmarkstammzellen
WO2002032378A2 (en) * 2000-10-20 2002-04-25 Tsuneya Ohno Fusion cells and cytokine compositions for treatment of disease
DE10139428A1 (de) * 2001-08-17 2003-03-27 Nemod Immuntherapie Ag Herstellung und Verwendung von humanen CD124 und CD116 positiven Tumorzelllinien zur Herstellung von allogenen oder semi-allogenen Immuntherapeutika
US20040115224A1 (en) * 2002-12-16 2004-06-17 Tsuneya Ohno Preparation and administration of hybrid cell vaccines for the prevention of cancer
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050180951A1 (en) * 2004-02-12 2005-08-18 Tsuneya Ohno Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
JPWO2005083062A1 (ja) * 2004-02-26 2008-01-17 ジェノミディア株式会社 細胞ワクチン
CA2558382A1 (en) * 2004-03-02 2005-09-15 Tsuneya Ohno Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
WO2006095330A2 (en) * 2005-03-10 2006-09-14 Yeda Research And Development Co. Ltd. Methods and immunogenic cell preparations for treating antigen-associated diseases
US20080031900A1 (en) * 2006-06-30 2008-02-07 Baylor Research Institute Dendritic Cells Generated Using GM-CSF and Interferon Alpha and Loaded with Heat-Treated and Killed Cancer Cells
CN109385400A (zh) * 2017-08-09 2019-02-26 科济生物医药(上海)有限公司 共表达pd-l1阻断剂的嵌合抗原受体修饰的免疫效应细胞
US20250319183A1 (en) 2021-04-07 2025-10-16 David Avigan Compositions and methods for the treatment of cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348878A (en) 1990-05-10 1994-09-20 Dana-Farber Cancer Institute Class I MHC-restricted T-T hybridomas, and a CD8-transfected BW5147, fusion partner therefor
PT633929E (pt) 1992-04-01 2004-07-30 Merix Bioscience Inc Metodo para proliferacao (in vitro) de precursores de celulas dentifricas e sua utilizacao para produzir imunogenios
WO1993020185A1 (en) 1992-04-01 1993-10-14 Steinman Ralph M Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
IT1264516B1 (it) 1993-05-31 1996-09-24 Biotop Sas Di Rita Cassarin Cellule dendritiche immortalizzate
KR100326132B1 (ko) * 1993-10-01 2002-07-31 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 호흡기마스크및이호흡기마스크에사용되는음성전달어댑터
WO1995016775A1 (en) 1993-12-14 1995-06-22 Yajun Guo Tumor cell fusions and methods for use of such tumor cell fusions
WO1996007733A1 (en) 1994-09-09 1996-03-14 Zymogenetics, Inc. Preparation of immortalized cells
DE69634750T2 (de) 1995-03-31 2006-02-23 Université Libre de Bruxelles DENDRITENZELLEN/TUMORZELLEN Hybirde ZUR INDUKTION EINER ANTI-TUMOR ANTWORT
WO1998017300A1 (en) * 1996-10-25 1998-04-30 Dana-Farber Cancer Institute, Inc. Mucin-mediated immunomodulation
WO2000057705A1 (en) 1999-03-31 2000-10-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens

Similar Documents

Publication Publication Date Title
JP2000509942A5 (https=)
JP2000509637A5 (https=)
JP2000507042A5 (https=)
JP2000509912A5 (https=)
JP2000509635A5 (https=)
JP2000510751A5 (https=)
JP2000509587A5 (https=)
JP2000507369A5 (https=)
JP2000507433A5 (https=)
JP2000508866A5 (https=)
JP2000510793A5 (https=)
JP2000508022A5 (https=)
JP2000508841A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2000510969A5 (https=)
JP2000510247A5 (https=)
JP2000508836A5 (https=)
JP2000508102A5 (https=)
JP2000509520A5 (https=)
JP2000509818A5 (https=)
JP2000507434A5 (https=)
JP2000508880A5 (https=)